I-Mab added to Nasdaq Biotechnology Index
I-Mab, a clinical stage biopharmaceutical company with U.S. offices in Gaitherburg and committed to the discovery, development and commercialization of novel biologics, Monday anno…
I-Mab, a clinical stage biopharmaceutical company with U.S. offices in Gaitherburg and committed to the discovery, development and commercialization of novel biologics, Monday anno…